To further assess the clinical value of ABCA6, ABCB11, ABCC6, and ABCG5 in patients with HCC, we re-analyzed the public datasets and focused on early-stage HCC (TNM stage I & II). Here, ABCA6 is linked to hepatocellular carcinoma.